| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 10/26/1994 | EP0621282A1 3-Deoxyoligosaccharides, process for their preparation and pharmaceutical compositions containing them |
| 10/26/1994 | EP0621037A1 Pyrido-pyrimidinediones, process for their preparation and their use as pharmaceuticals |
| 10/26/1994 | EP0620826A1 Tie, a novel endothelial cell receptor tyrosine kinase |
| 10/26/1994 | EP0620815A1 Phenol derivatives as agonists of a cyclic amp dependent protein kinase |
| 10/26/1994 | EP0620738A1 Fibrinolysis and fibrinogenolysis treatment with plasmin |
| 10/26/1994 | EP0620732A1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 10/26/1994 | CN1094093A Progenitor B cell stinulating factor |
| 10/26/1994 | CN1094092A Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
| 10/26/1994 | CN1094042A Improvements in or relating to benzothiophenes |
| 10/26/1994 | CN1094035A Carboxylic acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 10/26/1994 | CN1026323C Novel sulfonylphenyl-beta-D-thioxylosides, their method of preparation and their use in therapeutics |
| 10/25/1994 | US5358707 Oxidized variants of GM-CSF |
| 10/25/1994 | CA1332739C 4-chloro-3-sulfamoylbenzoic acid hydrazides, a process for the preparation thereof, pharmaceutical compositions containing them and their use as medicaments |
| 10/25/1994 | CA1332734C Natriuretic hormone |
| 10/24/1994 | CA2121735A1 Compound, leustroducsin h, its preparation and its therapeutic use |
| 10/19/1994 | EP0620279A1 Preparation of functional human urokinase proteins |
| 10/19/1994 | EP0620005A1 Use of hydroxyethylstarch for the improvement of the microcirculation |
| 10/19/1994 | EP0619802A1 A mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
| 10/19/1994 | EP0471701B1 Novel tnf-inhibit proteins and their preparation |
| 10/18/1994 | US5356922 Treatment of disturbances in microcirculation |
| 10/18/1994 | US5356921 Imidazolylphenol compounds, pharmaceutical compositions containing them, and processes for preparing such compounds and compositions |
| 10/18/1994 | US5356875 Anti-thrombin polypeptides and pharmaceutical compositions thereof |
| 10/18/1994 | US5356791 Mixing platelets or cancer cells with labelled platelet activating factor in presence of lipoproteins or cholesterol with and without antagonist, separating cells, measuring bound material |
| 10/13/1994 | WO1994022910A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
| 10/13/1994 | WO1994022909A1 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS |
| 10/13/1994 | WO1994022907A1 New urea derivates, their preparation and their use |
| 10/13/1994 | WO1994022835A2 Heterocyclic compounds as platelet aggregation inhibitors |
| 10/13/1994 | WO1994022834A1 Heterocyclic derivatives as platelet aggregation inhibitors |
| 10/13/1994 | WO1994022825A1 Fibrinogen receptor antagonists |
| 10/13/1994 | WO1994022820A1 1-amidinophenyl-pyrrolidones piperidinones azetinones as platelet aggregation inhibitors |
| 10/13/1994 | WO1994022499A1 Systemic effects of nitric oxide inhalation |
| 10/13/1994 | WO1994022456A1 Use of colloidal silicon dioxide for treating sickle-cell anemia, malaria and exogenously induced leukopenias |
| 10/13/1994 | CA2160156A1 Use of colloidal silicon dioxide for treating sickle-cell anemia, malaria and exogenously induced leukopenias |
| 10/13/1994 | CA2159482A1 Fibrinogen receptor antagonists |
| 10/13/1994 | CA2159072A1 Novel processes and intermediate compounds for the preparation of platelet glycoprotein iib/iiia inhibitors |
| 10/13/1994 | CA2159070A1 Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia |
| 10/13/1994 | CA2156070A1 Heterocyclic derivatives as platelet aggregation inhibitors |
| 10/13/1994 | CA2155307A1 Heterocyclic compounds as platelet aggregation inhibitors |
| 10/12/1994 | EP0618964A1 Novel tissue plasminogen activator variants |
| 10/12/1994 | EP0618926A1 New peptide derivatives |
| 10/12/1994 | CN1093254A Controlled-release pharmaceutical compositions containing nicergoline |
| 10/11/1994 | US5354934 Using aerosols |
| 10/11/1994 | US5354900 Diuretics, hypotensive agents |
| 10/11/1994 | US5354738 Amino acid derivatives |
| 10/11/1994 | US5354682 Therapeutic-grade, free of lipid envelope viruses, homogeneity and low concentrations of Blood Factors and prothrombin; stability; coagulants; wound dressings; surgery |
| 10/11/1994 | CA1332352C Therapeutic agent for prevention of intraventricular hemorrhage in premature infants |
| 10/11/1994 | CA1332307C Mineral supplements with sugar alcohol |
| 10/05/1994 | EP0618220A1 Method for purifying interleukin-4 |
| 10/05/1994 | EP0617966A1 Augmenting fetal hemoglobin by treatment with activin and/or inhibin and a method of in vitro diagnosis |
| 10/05/1994 | EP0617705A1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them. |
| 10/05/1994 | EP0617623A1 Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis |
| 10/05/1994 | EP0533695B1 IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY |
| 10/05/1994 | CN1093090A Cyclopeptides |
| 10/05/1994 | CN1026108C Novel 5-benzyl substituted-benzimidazo-line-2-thion derivatives and a process for preparing the same |
| 10/04/1994 | US5352810 Transesterification of diethylphosphonate or phosphoric triester with trimethylsilylbromide, treating with myoinositol protected at certain hydroxy groups in presence of condensing agent, removal of protecting groups |
| 10/04/1994 | US5352694 Pharmaceutical agents |
| 10/04/1994 | US5352667 Non-peptidic surrogates of the Arg-Gly-Asp sequence and pharmaceutical compositions comprising them |
| 10/04/1994 | US5352587 Genetic engineering |
| 10/04/1994 | US5352453 Acidic ph |
| 10/04/1994 | US5352452 Anticoagulants, enzyme activity |
| 10/04/1994 | CA1332237C N-sulphonamidoethyl-indolylpropionic acids and use thereof to inhibit thrombocyte aggregation |
| 09/29/1994 | WO1994021682A1 Selective crosslinking of hemoglobins by oxidized, ring-opened saccharides |
| 09/29/1994 | WO1994021673A1 Alpha-ketoamide derivatives as inhibitors of thrombosis |
| 09/29/1994 | WO1994021607A1 New heterocyclic compounds, their preparation and their use |
| 09/29/1994 | WO1994021275A1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine |
| 09/29/1994 | WO1994021235A1 Enhanced circulation effector composition and method |
| 09/29/1994 | WO1994021117A1 Method and apparatus for encapsulation of biologically-active substances in cells |
| 09/29/1994 | WO1994016094A3 Recombinant anti-vla4 antibody molecules |
| 09/29/1994 | WO1994015958A3 Peptide inhibitors of cell adhesion |
| 09/29/1994 | CA2158989A1 Alpha-ketoamide derivatives as inhibitors of thrombosis |
| 09/29/1994 | CA2157758A1 Compositions for use in human therapeutics, characterised by the association of a muramyl peptide with a cytokine |
| 09/29/1994 | CA2155842A1 Novel heterocycles, their preparation and their use |
| 09/28/1994 | CN1025999C ImidazoÛ4,5-BÙquinolinyloxyalkanoic acid amides with enhanced water solubility |
| 09/27/1994 | US5350759 Bis-aryl amide antagonists of platelet activating factor |
| 09/27/1994 | US5350753 Treatment of bacterial infectious diseases and septic shock |
| 09/27/1994 | US5350578 Inhibition of arterial thrombotic occlusion or thromboembolism |
| 09/27/1994 | CA1332149C Therapeutic agent for thrombocytopenia |
| 09/21/1994 | EP0615978A1 Peptide derivatives of the boronic acid having protease inhibiting activity, process for their production and pharmaceutical compositions comprising them |
| 09/20/1994 | US5349070 Salicylic acid-maltol conjugates |
| 09/20/1994 | US5348974 Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders |
| 09/15/1994 | WO1994020532A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 09/15/1994 | WO1994020526A1 Peptide boronic acid derivatives having protease inhibiting activity |
| 09/15/1994 | WO1994020478A1 Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions |
| 09/15/1994 | WO1994020468A1 4-aminopyridines, their production and use as an antithrombosis agent |
| 09/15/1994 | WO1994020467A1 New 4-aminopyridines, process for preparing the same and medicaments containing the same |
| 09/15/1994 | WO1994020128A1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 09/15/1994 | WO1994020085A1 Methods and compositions for inhibition of angiogenesis |
| 09/15/1994 | WO1994011394A3 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 09/15/1994 | CA2157215A1 New 4-aminopyridines - processes for their production as well as pharmaceutical agents containing them |
| 09/15/1994 | CA2156729A1 New 4-aminopyridines, processes for their production as well as pharmaceutical agents containing these compounds |
| 09/15/1994 | CA2153656A1 Peptide boronic acid derivatives having protease inhibiting activity |
| 09/14/1994 | EP0614981A1 Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
| 09/14/1994 | EP0614659A2 Pharmaceutical compositions in semisolid form and a device for administration thereof |
| 09/14/1994 | EP0614374A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 09/14/1994 | EP0614369A1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 09/14/1994 | EP0614368A1 Safe human transfusion blood |
| 09/14/1994 | EP0571485B1 3-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds |
| 09/14/1994 | EP0424405B1 Variants of plasminogen activators and processes for their production |
| 09/14/1994 | CN1092074A Diazepine derivatives |
| 09/13/1994 | CA1331992C Phenylacetonitriles which are substituted by basic groups, their preparation and drugs containing these substances |